Literature DB >> 19242068

Genetic polymorphisms modifying oxidative stress are associated with disease activity in rheumatoid arthritis patients.

Petra Bohanec Grabar1, Dussan Logar, Matija Tomsic, Blaz Rozman, Vita Dolzan.   

Abstract

Reactive oxygen and nitrogen species are involved in the pathology of rheumatoid arthritis (RA). Polymorphisms in genes coding for superoxide dismutases (SOD2 and SOD3), catalase (CAT), tumor necrosis factor-alpha (TNFA) and inducible NO synthase (NOS2A) may influence RA activity. We determined SOD2 Ala-9Val, SOD3 Arg213Gly, CAT C-262T, TNFA G-308A, TNFA C-857T and NOS2A (CCTTT) (n)polymorphisms in 327 RA patients. Carriers of CAT -262T and TNFA -308A allele had lower mean disease activity score of 28 joint count (DAS28) values than patients with CAT -262CC and TNFA -308GG genotypes (p = 0.014 and p = 0.046, respectively). Patients with the combination of CAT -262T and TNFA -308A allele had lower mean DAS28 values and a higher probability for low disease activity than non-carriers (p = 0.003, OR = 3.585, 95% CI = 1.538-8.357). Our results suggest that CAT and TNFA polymorphisms alone and in combination influence the activity of RA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19242068      PMCID: PMC3833245          DOI: 10.3233/DMA-2009-0603

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  9 in total

1.  Polymorphic variants of antioxidative defense enzymes and their gene-gene epistatic interactions in systemic lupus erythematode patients.

Authors:  Tatjana Jevtovic Stoimenov; Milena Despotovic; Sonja Stojanovic; Jelena Basic; Dušica Pavlovic
Journal:  Clin Rheumatol       Date:  2017-07-15       Impact factor: 2.980

2.  Association analysis of TNFR2, VDR, A2M, GSTT1, GSTM1, and ACE genes with rheumatoid arthritis in South Asians and Caucasians of East Midlands in the United Kingdom.

Authors:  Anant M Ghelani; Ash Samanta; Adrian C Jones; Sarabjit S Mastana
Journal:  Rheumatol Int       Date:  2010-04-18       Impact factor: 2.631

3.  Association of SOD2, GPX1, CAT, and TNF genetic polymorphisms with oxidative stress, neurochemistry, psychopathology, and extrapyramidal symptoms in schizophrenia.

Authors:  Marija Bošković; Tomaž Vovk; Marko Saje; Katja Goričar; Vita Dolžan; Blanka Kores Plesničar; Iztok Grabnar
Journal:  Neurochem Res       Date:  2012-12-02       Impact factor: 3.996

4.  Association between SOD1, CAT, GSHPX1 polymorphisms and the risk of inflammatory bowel disease in the Polish population.

Authors:  Malgorzata Mrowicka; Jerzy Mrowicki; Michal Mik; Radoslaw Wojtczak; Lukasz Dziki; Adam Dziki; Ireneusz Majsterek
Journal:  Oncotarget       Date:  2017-11-27

5.  Tumour necrosis factor gene polymorphisms in Egyptian patients with rheumatoid arthritis and their relation to disease activity and severity.

Authors:  Heba M Zaghlol; Sanaa Abdelshafy; Rabab A Mohamed; Enas A Abdelaleem
Journal:  Cent Eur J Immunol       Date:  2019-09-30       Impact factor: 2.085

6.  Is 4-Hydroxynonenal a Predictive Parameter for the Development of Joint Erosion in Patients With Rheumatoid Arthritis?

Authors:  Gürkan Akgöl; Hasan Ulusoy; Selda Telo; Arif Gülkesen; Tülay Yildirim; Ahmet Kürşad Poyraz; Arzu Kaya
Journal:  Arch Rheumatol       Date:  2016-03-22       Impact factor: 1.472

7.  Potential of ayurgenomics approach in complex trait research: leads from a pilot study on rheumatoid arthritis.

Authors:  Ramesh C Juyal; Sapna Negi; Preeti Wakhode; Sulekha Bhat; Bheema Bhat; B K Thelma
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

Review 8.  Genetic disorders coupled to ROS deficiency.

Authors:  Sharon O'Neill; Julie Brault; Marie-Jose Stasia; Ulla G Knaus
Journal:  Redox Biol       Date:  2015-07-17       Impact factor: 11.799

9.  Plasma and Synovial Fluid TrxR Levels are Correlated With Disease Risk and Severity in Patients With Rheumatoid Arthritis.

Authors:  Zhijun Xie; Jing Sun; Haichang Li; Tiejuan Shao; Dawei Wang; Qi Zheng; Chengping Wen
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.